Irit Reichenstein

Irit Reichenstein

Auto-generated profile, based on publicly available information

Irit Reichenstein

Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
IRIrit Reichenstein
Irit Reichenstein
CEChen Eitan
Chen Eitan
SDSandra Diaz-Garcia
Sandra Diaz-Garcia
GHGuy Haim
Guy Haim
IMIddo Magen
Iddo Magen
EHErn Hornstein
Ern Hornstein
Motor neuron–specific microRNA-218 (miR-218) has recently received attention because of its roles in mouse development. However, miR-218 relevance to human motor neuron disease was not yet explored. Here, we demonstrate by neuropathology that miR-218 is abundant in healthy human motor neurons. However, in amyotrophic lateral sclerosis (ALS) motor neurons, miR-218 is down-regulated and its mRNA targets are reciprocally up-regulated (derepressed). We further identify the potassium channel Kv10.1 as a new miR-218 direct target that controls neuronal activity. In addition, we screened thousands of ALS genomes and identified six rare variants in the human miR-218-2 sequence. miR-218 gene variants fail to regulate neuron activity, suggesting the importance of this small endogenous RNA for neuronal robustness. The underlying mechanisms involve inhibition of miR-218 biogenesis and reduced processing by DICER. Therefore, miR-218 activity in motor neurons may be susceptible to failure in human ALS, suggesting that miR-218 may be a potential therapeutic target in motor neuron disease.